QA: Marinus Pharmaceuticals INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001267813_2018_Marinus_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Ignoring company because Expenses is zero pre-agg {'balance_sheet': {'company_id': '0001267813', 'EntityCommonStockSharesOutstanding': 40525013, 'Assets': 75234000, 'AssetsCurrent': 73940000, 'ComprehensiveNetIncome': -36632000, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 6909000, 'LiabilitiesAndStockholdersEquity': 75234000, 'LiabilitiesCurrent': 6909000, 'LiabilitiesNoncurrent': 0, 'NetIncome': -36726000, 'PropertyPlantAndEquipmentNet': 1294000, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 0, 'remainder_ComprehensiveNetIncome': 94000, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 68325000, 'remainder_NetIncome': -36726000, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}}

Graph

Absolute values for 0001267813, Marinus Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 54,370,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,338,000
3 remainder_Assets 4,964,000
4 LiabilitiesCurrent 2,544,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 120,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 159,000
11 remainder_Revenues 0
12 remainder_NetIncome -18,739,000
13 remainder_ComprehensiveNetIncome -96,000
  yvar yval
0 Assets 60,672,000
1 Liabilities 2,664,000
2 Expenses 159,000
3 Revenues 0
4 StockholdersEquity 58,008,000
5 NetIncome -18,898,000
6 ComprehensiveNetIncome -18,946,000
7 BaseVar 41,165,000
8 EconomicCapitalRatiobeforeLimitedLiability 3.39
9 EconomicCapitalRatio 3.96

Edgar->Model Mapping

Feature Distribution

Change over Time